BACH1 and esophageal squamous cell carcinoma: In ESCC cells, BACH1 overexpression increases the abundance of PUFA-containing phospholipids and decreases the levels of MUFA-containing phospholipids, thereby increasing sensitivity to GPX4 inhibition (144).